Literature DB >> 9217683

Involvement of spinal recurrent inhibition in spasticity. Further insight into the regulation of Renshaw cell activity.

R Mazzocchio1, A Rossi.   

Abstract

Changes in the excitability of the soleus H-reflex are were studied after oral administration of L-acetylcarnitine, a cholinomimetic substance, in eight healthy control subjects and 23 spastic patients presenting with slowly progressive paraparesis (n = 10), a cord lesion (n = 9) and a cerebral lesion (n = 4). Changes in the amount of recurrent inhibition of soleus motor neurons at rest were also estimated in order to assess the level of activity of Renshaw cells before and after L-acetylcarnitine administration. Recurrent inhibition elicited by a conditioning reflex discharge (H1) was assessed by a subsequent test reflex (H'). Four patients lacked an H' reflex. In approximately 50% of the remaining patients, recurrent inhibition was normal, while in the other half there was evidence of reduced or absent inhibitory activity at rest. Pooling the data relative to the effect of L-acetylcarnitine on the H-reflex in relation to the strength of recurrent inhibition disclosed that the ratio of peak-to-peak amplitude values of the maximum H reflex to maximum M wave responses (Hmax:Mmax) was reduced in all the cases in which the recurrent inhibition at rest was normal, while such a reduction was never observed in the patients in whom recurrent inhibition was found to be decreased at rest. In the former cases, the size of the H' reflex evoked by the same conditioning H1 discharge was further depressed after L-acetylcarnitine, pointing to a potentiating effect of the drug on Renshaw cells; in the latter cases no such effect was seen. A significant decrease in the mean Hmax:Mmax ratio after L-acetylcarnitine intake was also seen in the healthy control subjects. Possible changes in the amount of presynaptic inhibition on Ia terminals on soleus motor neurons after L-acetylcarnitine were ruled out. It is proposed that the differential effect of the drug on the H-reflex excitability is directly related to the level of Renshaw cell activity, a reduction of which probably follows a lesion interrupting reticulo-spinal pathways with tonic facilitatory influences on Renshaw cells. These findings support the hypothesis that Renshaw cell excitability is set via cortico-reticulo-spinal systems.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9217683     DOI: 10.1093/brain/120.6.991

Source DB:  PubMed          Journal:  Brain        ISSN: 0006-8950            Impact factor:   13.501


  20 in total

Review 1.  Preclinical models of muscle spasticity: valuable tools in the development of novel treatment for neurological diseases and conditions.

Authors:  Anton Bespalov; Liudmila Mus; Edwin Zvartau
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2016-02-10       Impact factor: 3.000

2.  Nitrergic proprioceptive afferents originating from quadriceps femoris muscle are related to monosynaptic Ia-motoneuron stretch reflex circuit in the dog.

Authors:  Jozef Marsala; Nadezda Lukácová; Dalibor Kolesár; Karolína Kuchárová; Martin Marsala
Journal:  Cell Mol Neurobiol       Date:  2006 Oct-Nov       Impact factor: 5.046

3.  Motor units as tools to evaluate profile of human Renshaw inhibition.

Authors:  Mustafa Görkem Özyurt; Maria Piotrkiewicz; Betilay Topkara; Hans-Werner Weisskircher; Kemal Sitki Türker
Journal:  J Physiol       Date:  2019-02-06       Impact factor: 5.182

4.  The recurrent case for the Renshaw cell.

Authors:  Gardave S Bhumbra; B Anne Bannatyne; Masahiko Watanabe; Andrew J Todd; David J Maxwell; Marco Beato
Journal:  J Neurosci       Date:  2014-09-17       Impact factor: 6.167

5.  Rehabilitation Decreases Spasticity by Restoring Chloride Homeostasis through the Brain-Derived Neurotrophic Factor-KCC2 Pathway after Spinal Cord Injury.

Authors:  Henrike Beverungen; Samantha Choyke Klaszky; Michael Klaszky; Marie-Pascale Côté
Journal:  J Neurotrauma       Date:  2019-11-13       Impact factor: 5.269

6.  Muscle spasticity associated with reduced whole-leg perfusion in persons with spinal cord injury.

Authors:  Mandeep S Dhindsa; Curtis A Merring; Lauren E Brandt; Hirofumi Tanaka; Lisa Griffin
Journal:  J Spinal Cord Med       Date:  2011-11       Impact factor: 1.985

7.  Beyond muscular effects: depression of spinal recurrent inhibition after botulinum neurotoxin A.

Authors:  Véronique Marchand-Pauvert; Claire Aymard; Louis-Solal Giboin; Federica Dominici; Alessandro Rossi; Riccardo Mazzocchio
Journal:  J Physiol       Date:  2012-10-08       Impact factor: 5.182

8.  Modulatory effects of alpha1-,alpha2-, and beta -receptor agonists on feline spinal interneurons with monosynaptic input from group I muscle afferents.

Authors:  Ingela Hammar; Elzbieta Jankowska
Journal:  J Neurosci       Date:  2003-01-01       Impact factor: 6.167

9.  Comparison of transcutaneous electrical nerve stimulation (TENS) and functional electrical stimulation (FES) for spasticity in spinal cord injury - A pilot randomized cross-over trial.

Authors:  Anjali Sivaramakrishnan; John M Solomon; Natarajan Manikandan
Journal:  J Spinal Cord Med       Date:  2017-10-25       Impact factor: 1.985

10.  Muscle weakness and lack of reflex gain adaptation predominate during post-stroke posture control of the wrist.

Authors:  Carel G M Meskers; Alfred C Schouten; Jurriaan H de Groot; Erwin de Vlugt; Bob J J van Hilten; Frans C T van der Helm; Hans J H Arendzen
Journal:  J Neuroeng Rehabil       Date:  2009-07-23       Impact factor: 4.262

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.